Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies
Bäumler et al. · BMJ Open · 2021
Evidence Level
STRONGOBJECTIVE
Assess the risks of acupuncture-related adverse events through a systematic review
WHO
845,637 patients across 21 prospective studies
DURATION
Search through September 2019, covering more than 12.9 million treatments
POINTS
Not specified — general analysis of acupuncture safety
🔬 Study Design
Cohort studies
n=400000
Analysis of adverse events in German studies
Clinical trials
n=300000
Prospective documentation of adverse events
National surveys
n=145637
Safety surveys in the United Kingdom and other countries
📊 Results in numbers
Patients with at least one adverse event
Serious adverse events per 10,000 patients
Serious adverse events per 1 million treatments
Patients requiring medical treatment
Percentage highlights
📊 Outcome Comparison
Incidence of serious adverse events
This large study shows that acupuncture is very safe. Most adverse events are mild (such as minor bleeding at the needle site), and serious events are rare — only 1 in every 10,000 patients. Acupuncture can be considered one of the safest treatments in medicine.
Article summary
Plain-language narrative summary
Acupuncture is a millennia-old technique that has gained increasing popularity worldwide, offered by tens of thousands of physicians and health professionals. In Brazil, as in many other countries, it has become established as an important therapeutic option for various health conditions, especially chronic pain, headaches, postoperative nausea, and stress-related problems. Although there is solid scientific evidence regarding its efficacy for several medical conditions, questions about the safety of this practice still persist. It is essential that both patients and professionals have accurate information about the possible adverse effects of acupuncture in order to make informed decisions about its use.
This German study, published in BMJ Open in 2021, represents the first systematic review worldwide to mathematically calculate the risks of acupuncture-related adverse events. Researchers at the University of Munich systematically analyzed all available scientific literature through September 2019, looking for prospective studies that specifically evaluated the adverse effects of needle acupuncture. The methodology was rigorous, following international guidelines for systematic reviews and including only studies that followed patients over time. A total of 7,679 articles were initially identified, of which 22 met the established quality criteria, representing 21 independent studies that involved nearly 13 million acupuncture treatments.
Researchers categorized adverse events as mild or serious, with serious events being those that resulted in hospitalization, life-threatening conditions, or significant disability.
The results reveal a quite favorable safety profile for acupuncture. Out of every 100 patients who undergo a series of acupuncture sessions, approximately 9 may experience at least one mild adverse event. When considering individual treatments, approximately 8 of every 100 sessions may result in some adverse effect. It is important to note that half of these events are considered very mild and transient, such as minor bleeding at the needle site, transient pain, or redness around the insertion point.
Many specialists consider these effects as signs that the treatment is working properly, as they indicate the body is responding to the acupuncture stimulus. Serious adverse events are rare, occurring in approximately 1 in every 10,000 patients undergoing a series of treatments, or in roughly 8 cases per 1 million individual sessions. The most common serious events include pneumothorax (lung puncture), intense cardiovascular reactions that may cause fainting, and falls or trauma related to these reactions.
For patients, these results offer valuable information for treatment decision-making. Acupuncture can be considered one of the safest therapies in medicine, especially when compared to the adverse effects of medications commonly prescribed for chronic pain, such as anti-inflammatories and opioids. Patients should be aware that mild effects such as minor bleeding, transient pain, or fatigue after sessions are normal and generally indicate a positive response from the body. However, any prolonged discomfort or concerning symptoms should be immediately communicated to the practitioner.
For acupuncturists, the results emphasize the importance of solid medical training and proper instruction. Although serious events are rare, they require medical competence for adequate management and to minimize malpractice risks. The study highlights that most serious events can be avoided with appropriate training and correct technique.
The study presents some important limitations that should be considered. The main one is the considerable variability across the studies analyzed regarding the definition of what constitutes an acupuncture-related adverse event. Some studies included all events that occurred during treatment, regardless of their relationship to acupuncture, while others reported only events clearly caused by the procedure. In addition, there is ongoing debate in the scientific community about which local reactions should be considered adverse effects versus normal therapeutic responses.
The methodological quality of the studies also varied, with different forms of data collection and different definitions of severity. Another limitation is that many important studies published in Chinese were not included due to the language barrier, which may have influenced the results.
This work represents an important milestone in understanding the safety of acupuncture and provides essential data for evidence-based practice. The results confirm that acupuncture is among the safest treatments available in medicine, with very rare serious events and most adverse effects being mild and transient. To maximize safety, it is crucial that acupuncture be performed by properly trained professionals, especially considering the worldwide growth of this practice. The study also points to the need for international standardization in the definition and evaluation of adverse events in acupuncture studies, as well as clear criteria to distinguish adverse effects from desired therapeutic reactions.
Looking ahead, comparative studies that directly contrast the risks of acupuncture with those of conventional treatments for the same conditions will be important, further supporting informed clinical decision-making.
Strengths
- 1First comprehensive meta-analysis of acupuncture adverse events
- 2Very large sample with more than 845,000 patients
- 3Followed rigorous PRISMA guidelines
- 4Included risk-of-bias assessment
- 5Covered multiple countries and clinical settings
Limitations
- 1Substantial heterogeneity across included studies
- 2Variable definitions of adverse events
- 3Restriction to articles in English and German
- 4Difficulty distinguishing therapeutic reactions from adverse events
- 5Causality assessment limited to information reported in the articles
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
In day-to-day practice in a pain and rehabilitation service, the question about acupuncture safety comes up in virtually every referral consultation. This meta-analysis with more than 845,000 patients and nearly 13 million sessions offers the most robust answer published to date: only 9.31% of patients experience any adverse event over a treatment cycle, and the overwhelming majority of these events are mild and self-limited. The operationally most valuable data point is the serious-event rate — 1.01 per 10,000 patients and 7.98 per one million sessions — which places acupuncture in a safety tier far above that of routinely used analgesics, including nonsteroidal anti-inflammatory drugs and weak opioids. For populations with comorbidities that contraindicate conventional pharmacotherapy — frail older adults, patients with liver disease, those with kidney disease, pregnant patients — this risk profile formally justifies the inclusion of acupuncture in the therapeutic plan without the usual safety concerns that typically delay the referral.
▸ Notable Findings
The finding that most deserves attention is not the low rate of serious events itself, but the nature of those events: pneumothorax and vasovagal reactions with falls account for most serious occurrences. This has direct training implications — these are complications preventable through rigorous applied anatomy and a well-defined office protocol. The fact that only 0.114% of patients required additional medical intervention reinforces this reading. Another noteworthy aspect is that half of the registered adverse events were local microtraumas such as punctate bleeding and ecchymosis — effects that many services do not even classify as clinically relevant adverse events. The temporal breadth of the analyzed studies, from 1992 to 2019, and the multinational coverage lend historical stability to these numbers, suggesting that the safety profile is consistent regardless of the care setting.
▸ From My Experience
In my practice in the musculoskeletal pain outpatient clinic, I counsel patients before the first session with exactly these parameters: there is a real chance of ecchymosis or local pain for 24 to 48 hours, and this should not be interpreted as a sign of technical error. The vasovagal response is the event we manage most actively — we keep patients supine throughout the appointment as a routine, which practically eliminates falls. As for clinical progression, I have observed that patients with chronic musculoskeletal pain begin to report functional improvement between the third and fifth session, and a complete cycle of 8 to 12 sessions is usually enough to consolidate results and define monthly maintenance. I routinely combine acupuncture with a supervised exercise program and, when there is a relevant myofascial component, I add dry needling of trigger points in the same session. The profile that responds best, in my experience, is the patient with moderate-to-severe pain without a dominant neuropathic component who has already exhausted or cannot tolerate anti-inflammatories — exactly the scenario where these safety data make a difference for adherence.
Full original article
Read the full scientific study
BMJ Open · 2021
DOI: 10.1136/bmjopen-2020-045961
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories